BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6349537)

  • 1. [Postoperative immunochemotherapy of gastric cancer using levamisole].
    Hattori T
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):380-6. PubMed ID: 6349537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-tegafur combination therapy with or without levamisole. 1].
    Niimoto M; Hattori T; Itoh I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Toda T; Furusawa M; Koga S; Hashimoto I; Kondo T; Fujimoto S; Sugiyama Y; Abe O; Ohya M
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2133-47. PubMed ID: 6820890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of postoperative longterm chemotherapy against gastric cancer].
    Inokuchi K
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):320-5. PubMed ID: 6349534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-5-FU combination therapy with or without levamisole. 1].
    Niimoto M; Hattori T; Itoh I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Tsuji H; Furusawa M; Tomita M; Taguchi T; Kosaki G; Iwanaga T; Hioki K; Kondo T; Yura J; Hirano M; Miura K; Izuo M; Takemiya S
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2148-60. PubMed ID: 6820891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of immunochemotherapy on the cases of advanced gastric cancer stage III].
    Miwa H; Ono F; Kobayashi T; Orita K
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1735-41. PubMed ID: 6820882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative immunochemotherapy (BCG + 5-FU) in advanced gastric cancer.
    Popiela T; Zembala M; Kulig J; Czupryna A; Uracz W
    Anticancer Res; 1988; 8(6):1423-7. PubMed ID: 3064717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Levamisole in adjuvant immunochemotherapy for gastric cancer; a prospective randomized controlled study.
    Hattori T; Niimoto M; Toge T; Oride M; Nakao A; Yoshinaka K
    Jpn J Surg; 1983 Nov; 13(6):480-5. PubMed ID: 6423870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report.
    Cafiero F; Gipponi M; Lionetto R;
    J Surg Oncol; 2003 Jul; 83(3):140-6. PubMed ID: 12827681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effectiveness of S-1 based sequential chemotherapy as second-line treatment for advanced/recurrent gastric cancer].
    Sugimoto N; Narahara H; Sakai D; Yamamoto S; Fumoto S; Yagi T; Imamura F; Iishi H; Tatsuta M
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):417-24. PubMed ID: 19295265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.
    Witte RS; Cnaan A; Mansour EG; Barylak E; Harris JE; Schutt AJ
    Cancer; 2001 Mar; 91(5):1020-8. PubMed ID: 11251955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of levamisole hydrochloride on advanced and recurrent breast cancer--LMS randomized controlled study of a group responding to CAF (cyclophosphamide, adriamycin, and 5-FU) therapy].
    Taguchi T; Izuo M; Ogawa N; Hayasaka H; Akai S; Tazima S; Fujii G; Tominaga T; Okamoto T; Kubo K; Yoshida M; Ota K; Sakai K; Hattori T; Inoue G; Nomura Y
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1595-608. PubMed ID: 6764119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phase III multi-center study of levamisole (LMS)--a randomized evaluation in advanced gastrointestinal cancer, with special reference to stomach cancer].
    Wakui A; Kikuchi K; Yokoyama M; Takahashi K; Yoshida Y; Kaito I; Matsuoka T; Ishikawa M; Goto Y; Ono K; Kikkawa J; Sugahara K; Taima T
    Gan To Kagaku Ryoho; 1983 Jul; 10(7):1610-23. PubMed ID: 6347085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunochemotherapy of resectable lung cancer--a preliminary study on a comparison of the control, levamisole, and OK-432].
    Okayasu T; Kashimura Y; Matano J; Kawabata M; Takeoka T; Hashimoto M; Tanabe T
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1646-52. PubMed ID: 6764120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
    Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ
    J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of levamisole immunotherapy and polychemotherapy in advanced breast cancer.
    Klefström P
    Cancer Treat Rep; 1980 Jan; 64(1):65-72. PubMed ID: 6991105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portal vein chemotherapy for colorectal cancer: a meta-analysis of 4000 patients in 10 studies. Liver Infusion Meta-analysis Group.
    J Natl Cancer Inst; 1997 Apr; 89(7):497-505. PubMed ID: 9086006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective randomized study of post-operative chemotherapy with levamisole and UFT for head and neck carcinoma.
    Lam P; Yuen AP; Ho CM; Ho WK; Wei WI
    Eur J Surg Oncol; 2001 Dec; 27(8):750-3. PubMed ID: 11735172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of adoptive immunotherapy with tumor-associated lymphocytes in patients with advanced gastric cancer: a randomized trial.
    Kono K; Takahashi A; Ichihara F; Amemiya H; Iizuka H; Fujii H; Sekikawa T; Matsumoto Y
    Clin Cancer Res; 2002 Jun; 8(6):1767-71. PubMed ID: 12060615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled study of postoperative adjuvant immunochemotherapy with Nocardia rubra cell wall skeleton (N-CWS) and Tegafur for gastric carcinoma.
    Koyama S; Ozaki A; Iwasaki Y; Sakita T; Osuga T; Watanabe A; Suzuki M; Kawasaki T; Soma T; Tabuchi T
    Cancer Immunol Immunother; 1986; 22(2):148-54. PubMed ID: 3087619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.